Please provide your email address to receive an email when new articles are posted on . Amitriptyline was superior to placebo and increased the odds of relief from IBS symptoms. Researchers noted that ...

Despite amitriptyline missing the primary endpoint of significantly improving pain relief, disability, and work-related outcomes at 6 months for people with chronic low back pain, shorter term ...

GLASGOW, United Kingdom ― Amitriptyline, titrated at low dose, was superior to placebo as a second-line treatment for irritable bowel syndrome (IBS) across multiple outcomes in what the researchers ...

Irritable Bowel Syndrome (IBS) is a complex and often frustrating condition affecting millions worldwide. Finding effective treatments can be challenging, but a recent clinical trial has shed light on ...

A cheap and widely available prescription drug can improve symptoms of irritable bowel syndrome in patients seen in GP surgeries, new research presented today at UEG Week 2023 has found. Amitriptyline ...

Titrated low-dose amitriptyline significantly improved irritable bowel syndrome (IBS) symptoms when used as a second-line treatment in the primary care setting, the randomized ATLANTIS trial showed.